Research Site

Burnaby, British Columbia V5H 4K7

1 studies enrolling now · 10 studies all time

What they study most

Acute Coronary Syndrome, Bone Metastases, Cancer, Hematologic Malignancies, Hyperlipidemia, Hyperlipidemia and Mixed Dyslipidemia, Mixed Dyslipidemia, Multiple Myeloma, Multiple Myeloma Bone Lesions, Multiple Sclerosis, Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorder

Studies at this site

• Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS — Recruiting now
• An Efficacy and Safety Study of Ravulizumab in Adult Participants With NMOSD — Completed
• Dimethyl Fumarate (DMF) Observational Study — Completed
• Study to Assess in Home Use of Evolocumab (AMG 145) Administration Using Either an Automated Mini-doser or a Prefilled Autoinjector/Pen — Completed
• LAPLACE-TIMI 57: Low-density Lipoprotein Cholesterol (LDL-C) Assessment With PCSK9 monoclonaL Antibody Inhibition Combined With Statin thErapy — Completed
• LDL-C Assessment With PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy-2 — Completed
• Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma — Completed
• Open-label Extension Study of Evolocumab (AMG 145) in Adults With Hyperlipidemia and Mixed Dyslipidemia — Completed
• Observational Study to Characterize Real-world Clinical Outcomes With Relapsing-remitting Multiple Sclerosis (RRMS) — Completed
• Efficacy and Safety of Oral BG00012 in Relapsing-Remitting Multiple Sclerosis — Completed